61 related articles for article (PubMed ID: 27696134)
1. GDPD5, a choline-generating enzyme and its novel role in tumor cell migration.
Marchan R
Arch Toxicol; 2016 Dec; 90(12):3143-3144. PubMed ID: 27696134
[No Abstract] [Full Text] [Related]
2. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
3. Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.
Stewart JD; Marchan R; Lesjak MS; Lambert J; Hergenroeder R; Ellis JK; Lau CH; Keun HC; Schmitz G; Schiller J; Eibisch M; Hedberg C; Waldmann H; Lausch E; Tanner B; Sehouli J; Sagemueller J; Staude H; Steiner E; Hengstler JG
Proc Natl Acad Sci U S A; 2012 May; 109(21):8155-60. PubMed ID: 22570503
[TBL] [Abstract][Full Text] [Related]
4. Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
Grinde MT; Skrbo N; Moestue SA; Rødland EA; Borgan E; Kristian A; Sitter B; Bathen TF; Børresen-Dale AL; Mælandsmo GM; Engebraaten O; Sørlie T; Marangoni E; Gribbestad IS
Breast Cancer Res; 2014 Jan; 16(1):R5. PubMed ID: 24447408
[TBL] [Abstract][Full Text] [Related]
5. The role and therapeutic potential of the autotaxin-lysophosphatidate signalling axis in breast cancer.
Teo K; Brunton VG
Biochem J; 2014 Oct; 463(1):157-65. PubMed ID: 25195735
[TBL] [Abstract][Full Text] [Related]
6. Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer.
Moestue SA; Giskeødegård GF; Cao MD; Bathen TF; Gribbestad IS
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):E2506; author reply E2507. PubMed ID: 22851771
[No Abstract] [Full Text] [Related]
7. [Effect of PC-1 gene expression on migration ability of prostate cancer cells].
Zhang H; Wan LC; Wang J; Zhou JG; Huang CF
Ai Zheng; 2005 Sep; 24(9):1043-7. PubMed ID: 16159422
[TBL] [Abstract][Full Text] [Related]
8. Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.
Wijnen JP; Jiang L; Greenwood TR; Cheng M; Döpkens M; Cao MD; Bhujwalla ZM; Krishnamachary B; Klomp DW; Glunde K
NMR Biomed; 2014 Jun; 27(6):692-9. PubMed ID: 24764256
[TBL] [Abstract][Full Text] [Related]
9. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
[TBL] [Abstract][Full Text] [Related]
10. Structure and biological function of ENPP6, a choline-specific glycerophosphodiester-phosphodiesterase.
Morita J; Kano K; Kato K; Takita H; Sakagami H; Yamamoto Y; Mihara E; Ueda H; Sato T; Tokuyama H; Arai H; Asou H; Takagi J; Ishitani R; Nishimasu H; Nureki O; Aoki J
Sci Rep; 2016 Feb; 6():20995. PubMed ID: 26888014
[TBL] [Abstract][Full Text] [Related]
11. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
12. Fhit proteins can also recognize substrates other than dinucleoside polyphosphates.
Guranowski A; Wojdyła AM; Pietrowska-Borek M; Bieganowski P; Khurs EN; Cliff MJ; Blackburn GM; Błaziak D; Stec WJ
FEBS Lett; 2008 Sep; 582(20):3152-8. PubMed ID: 18694747
[TBL] [Abstract][Full Text] [Related]
13. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
[TBL] [Abstract][Full Text] [Related]
14. Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression.
Benesch MG; Tang X; Dewald J; Dong WF; Mackey JR; Hemmings DG; McMullen TP; Brindley DN
FASEB J; 2015 Sep; 29(9):3990-4000. PubMed ID: 26071407
[TBL] [Abstract][Full Text] [Related]
15. B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.
Li W; Zou ST; Zhu R; Wan JM; Xu Y; Wu HR
Mol Med Rep; 2014 Jun; 9(6):2374-80. PubMed ID: 24714932
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study.
Daly PF; Zugmaier G; Sandler D; Carpen M; Myers CE; Cohen JS
Cancer Res; 1990 Feb; 50(3):552-7. PubMed ID: 2153442
[TBL] [Abstract][Full Text] [Related]
17. Memo is a copper-dependent redox protein with an essential role in migration and metastasis.
MacDonald G; Nalvarte I; Smirnova T; Vecchi M; Aceto N; Dolemeyer A; Frei A; Lienhard S; Wyckoff J; Hess D; Seebacher J; Keusch JJ; Gut H; Salaun D; Mazzarol G; Disalvatore D; Bentires-Alj M; Di Fiore PP; Badache A; Hynes NE
Sci Signal; 2014 Jun; 7(329):ra56. PubMed ID: 24917593
[TBL] [Abstract][Full Text] [Related]
18. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.
Chai P; Tian J; Zhao D; Zhang H; Cui J; Ding K; Liu B
Biochem Biophys Res Commun; 2016 Feb; 471(1):123-8. PubMed ID: 26828271
[TBL] [Abstract][Full Text] [Related]
19. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
Parr C; Jiang WG
Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
[TBL] [Abstract][Full Text] [Related]
20. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
